Search

Your search keyword '"Miyo, Masaaki"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Miyo, Masaaki" Remove constraint Author: "Miyo, Masaaki" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
119 results on '"Miyo, Masaaki"'

Search Results

1. Predicting Generalization of AI Colonoscopy Models to Unseen Data

2. ctDNA-based molecular residual disease and survival in resectable colorectal cancer

6. Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group

7. Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.

13. Association of circulating tumor DNA (ctDNA) molecular disease (MRD) detection with lymph node metastasis after local excision of pathological T1 colorectal cancer: First results from DENEB, a CIRCULATE-Japan GALAXY substudy.

14. Cylindrical abdominoperineal resection for rectal cancer using the Hugo RAS system: The first ever case report for rectal cancer.

15. Tele‐proctoring for minimally invasive surgery across Japan: An initial step toward a new approach to improving the disparity of surgical care and supporting surgical education

16. O4-5 Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: GALAXY study in the CIRCULATE-Japan

17. Tele‐proctoring for minimally invasive surgery across Japan: An initial step toward a new approach to improving the disparity of surgical care and supporting surgical education.

18. Postoperative circulating tumor DNA-based molecular residual disease in patients with BRAF V600E and MSI-H colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.

19. Right hemicolectomy for ascending colon cancer using the hinotori surgical robot system: The first ever case report for colon cancer

20. Supplemental Figures S1-S13 and Tables S1-S3 from Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer

21. Data from Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer

23. Data from MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells

25. The proteasome activities of LPACs and non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

27. The list of universally elevated genes in LPACs of all cell lines using microarray analysis. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

28. Data from MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells

29. Analysis of LPACs and non-LPACs based on various stem cell markers. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

30. Supplementary Material from MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells

31. The confirmation of stable ZsGreen expression in CRC cell lines. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

32. The validation of over-expression of EID3 and down- regulation of EID3. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

33. Supplementary Figures from MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells

34. Relationship between EID3 expression and clinicopathological factors in patients with colorectal cancer from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

35. LPACs were not detected transitioning from non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

36. Validation of EID3 expression in LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

38. Clinical development and evaluation of plasma angiogenesis factors from phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD): RAINCLOUD-TR.

40. A Case of Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms of the Esophagus with Rapid Progression of Postoperative Metastatic Recurrence Accompanying Trousseau’s Syndrome

41. Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study.

42. Essential updates 2020/2021: Advancing precision medicine for comprehensive rectal cancer treatment.

43. DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy

44. Impact of the COVID‐19 pandemic on colorectal cancer surgery in Japan: Clinical Study Group of Osaka University―A multicenter retrospective study.

45. case of infectious heterotopic ossification in the appendectomy scar, which formed an inflammatory granuloma.

46. Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.

47. Descending Colon Cancer Resection Using the da Vinci SP with an Access Port kit: World's First Case.

48. Hybrid Abdominal Robotic Approach Using the hinotori™ Surgical Robot System with Transanal Total Mesorectal Excision for Rectal Cancer: The First Ever Case Report for Rectal Cancer.

49. Questionnaire to Survey Cosmetic Outcomes in Laparoscopic Surgery for Colorectal Cancer.

50. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.

Catalog

Books, media, physical & digital resources